Related Topics
How the 2020 election might shape U.S. health policy
Two Harvard Chan School experts explored the implications of the 2020 election for the future of U.S. health policy in a special report in the New England Journal of Medicine.
Where post-election health care may be headed
After the election, changes are likely on the docket for the Affordable Care Act, telehealth, and the COVID-19 response, according to Harvard Chan School health policy expert Benjamin Sommers.
Op-ed: Public health researchers should get political
It’s time for researchers to step into politics, according to Mary Bassett, director of the François-Xavier Bagnoud (FXB) Center for Health and Human Rights at Harvard University and FXB Professor of the Practice of Health and Human Rights…
Advertising by chain restaurants linked to adult weight gain in low-income areas
Unhealthy food and beverage marketing by chain restaurants is associated with modest weight gain among adults living in low-income U.S. counties.
Philanthropic Impact Fall 2020
Putting disordered eating at the center of public health discourse; Investing in the intersection of public health and business
Viewpoint: Unhealthy food sold in the U.S. should carry clear warning labels
Food products sold in the U.S. that contain high levels of unhealthy nutrients should be marked with prominent warning labels on the front of the product packaging, according to an October 1, 2020 JAMA Viewpoint article. The article…
ACA has ‘literally been a lifesaver’
Repealing the ACA during the coronavirus pandemic could lead to devastating consequences for millions of Americans, says Benjamin Sommers.
The Connected Crisis
The COVID-19 pandemic has inspired new research directions across the School
Arkansas’ Medicaid work requirement policy failed, study finds
A work requirement policy imposed by the state of Arkansas on Medicaid participants failed to achieve its stated goal of boosting employment, according to new research led by Harvard T.H. Chan School of Public Health. Instead, the policy…
Decision on convalescent plasma for COVID-19 raises questions
Howard Koh, professor of the practice of public health, discusses the FDA's decision to allow the use of convalescent plasma as a treatment for COVID-19.
